Reda SM, Cant AJ

Language: Spanish
References: 7
Page: 3-4
PDF size: 88.16 Kb.

Text Extraction

No abstract

REFERENCES

1. Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol. 2014; 133 (4): 961-966.

2. Papadopoulou-Alataki E, Hassan A, Davies EG. Prevention of infection in children and adolescents with primary immunodeficiency disorders. Asian Pac J Allergy Immunol. 2012; 30 (4): 249-258.

3. Principi N, Esposito S. Vaccine use in primary immunodeficiency disorders. Vaccine. 2014; 32 (30): 3725-3731.

4. Martin J. Vaccine-derived poliovirus from long term excretor and the end game of polio eradication. Biologicals. 2006; 34: 117-122.

5. Chapel H, Cunningham-Rundles C. Update in understanding common variable immuno-deficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009; 145: 709-727.

6. Kerr J, Quinti I, Eibl M, Chapel H, Späth PJ, Sewell WA et al. Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe. Front Immunol. 2014; 5: 629.

7. World Health Organization (WHO) Lists (Adult and Pediatric) of Essential medicines.